BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 28738783)

  • 1. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
    Lei L; Liu Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 for heart failure.
    Madmani ME; Yusuf Solaiman A; Tamr Agha K; Madmani Y; Shahrour Y; Essali A; Kadro W
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008684. PubMed ID: 24049047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 for heart failure.
    Al Saadi T; Assaf Y; Farwati M; Turkmani K; Al-Mouakeh A; Shebli B; Khoja M; Essali A; Madmani ME
    Cochrane Database Syst Rev; 2021 Feb; (2)(2):CD008684. PubMed ID: 35608922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction.
    Gui Y; Chen J; Hu J; Ouyang M; Deng L; Liu L; Sun K; Tang Y; Xiang Q; Xu J; Zhu L; Peng Z; Zou P; Li B; Zheng Z; Xu D
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):503-513. PubMed ID: 32394177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of coenzyme Q10 in patients with congestive heart failure.
    Khatta M; Alexander BS; Krichten CM; Fisher ML; Freudenberger R; Robinson SW; Gottlieb SS
    Ann Intern Med; 2000 Apr; 132(8):636-40. PubMed ID: 10766682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.
    Pierce JD; Mahoney DE; Hiebert JB; Thimmesch AR; Diaz FJ; Smith C; Shen Q; Mudaranthakam DP; Clancy RL
    BMC Cardiovasc Disord; 2018 Apr; 18(1):57. PubMed ID: 29606104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment.
    Morisco C; Nappi A; Argenziano L; Sarno D; Fonatana D; Imbriaco M; Nicolai E; Romano M; Rosiello G; Cuocolo A
    Mol Aspects Med; 1994; 15 Suppl():s155-63. PubMed ID: 7752827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL
    Kardiologiia; 2022 Jun; 62(6):3-14. PubMed ID: 35834336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials.
    Hwang IC; Kim YJ; Park JB; Yoon YE; Lee SP; Kim HK; Cho GY; Sohn DW
    BMC Cardiovasc Disord; 2017 Jun; 17(1):150. PubMed ID: 28606099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
    JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Zheng SL; Chan FT; Nabeebaccus AA; Shah AM; McDonagh T; Okonko DO; Ayis S
    Heart; 2018 Mar; 104(5):407-415. PubMed ID: 28780577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ
    Cardiol J; 2019; 26(2):147-156. PubMed ID: 30835327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 treatment in serious heart failure.
    Munkholm H; Hansen HH; Rasmussen K
    Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Tao J; Liu X; Bai W
    Front Endocrinol (Lausanne); 2020; 11():110. PubMed ID: 32231640
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.
    Holland DJ; Kumbhani DJ; Ahmed SH; Marwick TH
    J Am Coll Cardiol; 2011 Apr; 57(16):1676-86. PubMed ID: 21492765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.